7 December 2011 – Parsortix update

The group has announced that its US subsidiary, Parsortix Inc. has signed a research agreement with the University of Surrey’s Oncology Department.  This is a leading UK cancer centre and the move is the first as ANGLE seeks to develop relationships with several leading cancer research centres.  These should help the development of the technology and the shares remain a BUY.